Your session is about to expire
← Back to Search
Enteral Nutrition for Premature Birth (ENACT Trial)
ENACT Trial Summary
This trial is testing whether earlier, exclusive enteral nutrition (through the gut) is better for preterm infants than delayed enteral nutrition and prolonged use of parenteral nutrition (through the veins).
ENACT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ENACT Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not have major birth defects or genetic disorders.You have a serious illness and have decided to stop receiving treatment.
- Group 1: Progressive Enteral Nutrition
- Group 2: Exclusive Enteral Nutrition
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does the age-limit for this research study extend beyond 75 years of age?
"The enrollment criteria for this research dictates that participants must have been born within the last 48 hours, with a minimum age of one hour."
Who is eligible to take part in this investigative study?
"To be eligible to join this trial, participants must have been born pre-term between 1 Hour and 48 Hours old. This medical research is looking for a collective 102 patients."
Is enrollment in this research project currently available to participants?
"According to the information available on clinicialtrials.gov, this trial is no longer actively seeking patients for enrollment. Initially posted on May 27th 2021 and last edited October 18th 2022, it appears that recruitment has been paused; however, there are 5 other trials simultaneously engaging with participants at present."
Share this study with friends
Copy Link
Messenger